Both in Surgical Instruments
Orchestra BioMed Holdings vs Avita Medical
Over the past year OBIO returned +147.2% and RCEL returned +122.7%; their daily moves had a correlation of 0.18.
OBIO +147.2% RCEL +122.7%Growth of $1, one year, split-adjusted
| Metric | OBIO | RCEL |
|---|---|---|
| Price | $6.08 | $11.96 |
| Market cap | $365.4M | $369.9M |
| Today | +3.23% | +2.48% |
| 1 month | +17.3% | +15.6% |
| 6 months | +49.4% | +229.5% |
| Year to date | +46.5% | +246.7% |
| 1 year | +151.2% | +130.0% |
| Revenue growth (YoY) | −89.5% | +17.8% |
| Gross margin | 71.6% | 81.9% |
| Net margin | −27362.5% | −35.3% |
| P/E (TTM) | — | — |
| Price / sales | 11.4× | 4.9× |
| Net cash | $75.1M | -$35.5M |
| Dividend yield | — | — |
| Volatility (60d) | 59.1% | 127.6% |
| Short % of float | 7.6% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).